As a preclinical CRO specializing in oncology, Alfa Cytology offers gene knockout cell line construction services utilizing CRISPR/Cas9 gene editing technology to precisely knock out target genes and generate loss-of-function cellular models, providing reliable tools for your cancer gene function studies and drug target validation.
Gene knockout cell lines are engineered cellular models in which specific genes are rendered functionally inactive through precise genome editing. The CRISPR/Cas9 system, the most widely adopted tool for gene knockout, utilizes a single guide RNA (sgRNA) to direct Cas9 nuclease to the target genomic locus, inducing a double-strand break (DSB). Repair via the error-prone non-homologous end joining (NHEJ) pathway introduces random insertions or deletions (indels), frequently resulting in frameshift mutations and complete loss of protein function. Gene knockout cell lines are recognized as the gold standard for gene function studies and drug target validation. By establishing loss-of-function cellular models, researchers can directly assess the biological roles of target genes in tumor initiation, progression, metastasis, and drug resistance, providing the most direct genetic evidence for target discovery and validation. Consequently, gene knockout cell lines have become indispensable core tools in cancer research and preclinical drug discovery, powering mechanistic studies, pharmacodynamic evaluations, and the development of precision therapeutic strategies.
Fig. 1 Flowchart for generating CRISPR-mediated knockout cancer cell lines using transient transfection. (Mousavi Kahaki SA, et al.; 2024)
With an in-depth understanding of CRISPR gene editing technology and tumor biology, Alfa Cytology provides professional gene knockout cell line construction services dedicated to translating your target research needs into precise, reliable, and thoroughly validated loss-of-function cellular models. Leveraging our extensive editing experience across diverse tumor cell lines and a rigorous quality system, we ensure that every gene knockout cell line we deliver exhibits precise gene editing, complete protein ablation, and stable genetic characteristics, providing reliable cellular tools for your gene function studies and target validation.
| Service Step | Service Details | Turnaround Time |
|---|---|---|
| sgRNA Design and Vector Construction | Design 3–4 sgRNAs targeting key exons, assess off-target effects in silico, construct into CRISPR/Cas9 vectors, and verify by sequencing.
|
2–3 weeks |
| Cell Transfection and Selection | Deliver CRISPR/Cas9 vectors via lentiviral, electroporation, or lipid-based methods, and enrich transfected cells by antibiotic selection or reporter expression.
|
2–3 weeks |
| Single-Cell Isolation | Isolate single cells into 96-well plates via limiting dilution or FACS sorting to ensure monoclonality.
|
1 week |
| Clone Screening and Down-Selection | Expand clones from 96-well to 6-well plates, screen by T7E1 or Sanger sequencing, confirm genotypes by target region sequencing, and down-select to 2–3 candidates.
|
2–3 weeks |
| Protein Knockout Validation | Confirm protein knockout by Western blot and validate phenotypic changes through functional assays.
|
2–3 weeks |
| Off-Target Effect Analysis |
|
2–3 weeks |
| Cell Banking and Quality Release | Establish master cell bank (MCB) and working cell bank (WCB). Complete full release testing and issue a comprehensive COA. |
3–4 weeks |
Our gene knockout cell line construction services support a broad spectrum of oncology research, from fundamental cancer biology to translational drug discovery. By providing precisely engineered loss-of-function cellular models across diverse cancer types, we enable researchers to dissect the genetic drivers of tumorigenesis, identify and validate novel therapeutic targets, and elucidate drug response and resistance mechanisms. Alfa Cytology's platform is adaptable to virtually any tumor cell line of interest, empowering your research across the full spectrum of oncology disciplines, including but not limited to:
Ready to advance your oncology research with our gene knockout cell line construction services? Whether your project requires a single-gene knockout cell line for drug target validation or a multi-gene knockout cell line for mechanistic studies of drug resistance, Alfa Cytology is fully equipped to assist. Please don't hesitate to contact us to discuss your specific gene knockout cell line needs and discover how our expertise can expedite your oncology research programs.
Reference
For research use only.
Alfa Cytology, a preclinical research solution provider, provides its clients with one-stop solutions to accelerate cancer therapeutics discovery and development.
Copyright © 2026 Alfa Cytology. All rights reserved.
